Stay updated on Risankizumab in PsA Patients: Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest updates to the Risankizumab in PsA Patients: Clinical Trial page
- Check6 days agoChange DetectedExpanded the Locations section with numerous new sites across multiple regions and removed several existing locations.SummaryDifference3%
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section updated: two 2025 publications added and one 2025 publication removed, all related to the KEEPsAKE program. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check28 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check35 days agoChange DetectedThe Publications section received minor wording updates: added clarifications that publications are provided voluntarily and may come from PubMed, and updated the revision from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page removed a government funding status notice, a generic operational message unrelated to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check56 days agoChange DetectedNo additions or deletions were detected between the two screenshots; the Study Details page content and layout appear unchanged.SummaryDifference0.1%
Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.